Bio-Gene Technology Secures $2.1 Million for Key Insecticide Development

Bio-Gene Technology Ltd. ( (AU:BGT) ) has shared an announcement.

Bio-Gene Technology Ltd announced a successful capital raise of $2.1 million through a placement with sophisticated investors and plans to offer a Share Purchase Plan to eligible shareholders. The funds will be used to conduct regulatory-enabling safety studies for Flavocide®, a key step towards its approval in Australia, and to support the scale-up of Qcide, product development, and strategic projects. This financial boost is expected to significantly advance Bio-Gene’s operational capabilities and strengthen its position in the pest control industry.

More about Bio-Gene Technology Ltd.

Bio-Gene Technology Ltd is an Australian company specializing in the development of new insecticides derived from natural sources. The company focuses on creating high-impact solutions for pest control, with products like Flavocide® and Qcide aimed at achieving regulatory approval and commercial scale-up.

YTD Price Performance: -41.86%

Average Trading Volume: 156,353

Technical Sentiment Signal: Buy

Current Market Cap: A$5.03M

See more insights into BGT stock on TipRanks’ Stock Analysis page.